Aurinia Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$14.41

+0.20 (+1.41%)

As of Mar 25, 1:35 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 9 69%

Hold 4 31%

Sell 0 0%

Price Target

Analyst Price Target +182.0% upside

Low Target $34.07

Average Target $40.64

High Target $61.77

Current Price $14.41

Current
$14.41

Target
$40.64

$34.07 $40.64 avg $61.77

Scenario Analysis

Bear Case

$34.07

136.4%

Low target

Base Case

$40.64

+182.0%

Avg target

Bull Case

$61.77

+328.7%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$16.54

-12.9% from high

52-Week Low

$6.83

+111.1% from low

Target vs 52W High

$40.64

+145.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%